BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4276540)

  • 1. Proceedings: Morphine-cannabinoid-interactions in rats and mice.
    Fernandes M; Hill R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R19. PubMed ID: 4276540
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine beta-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence.
    Bhargava HN; Way EL
    J Pharmacol Exp Ther; 1974 Jul; 190(1):165-75. PubMed ID: 4858783
    [No Abstract]   [Full Text] [Related]  

  • 3. Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice.
    Brase DA; Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 May; 197(2):317-25. PubMed ID: 944771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence.
    Cicero TJ; Meyer ER
    J Pharmacol Exp Ther; 1973 Feb; 184(2):404-8. PubMed ID: 4734581
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishment of physical dependence mice by oral ingestion of morphine.
    McMillan DE; Waddell FB; Cathcart CF
    J Pharmacol Exp Ther; 1974 Sep; 190(3):416-9. PubMed ID: 4472104
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of p-chlorophenylalanine on morphine tolerance and physical dependence and regional brain serotonin turnover studies in morphine tolerant-dependent mice.
    Ho IK; Lu SE; Stolman S; Loh HH; Way EL
    J Pharmacol Exp Ther; 1972 Jul; 182(1):155-65. PubMed ID: 4261222
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat.
    Winters WD; Hance AJ; Cadd GG; Quam DD; Benthuysen JL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):51-7. PubMed ID: 3336011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.
    Cheng HY; Laviolette SR; van der Kooy D; Penninger JM
    Eur J Neurosci; 2004 Jun; 19(11):3033-41. PubMed ID: 15182311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclic 3',5'-adenosine monophosphate on morphine tolerance and physical dependence.
    Ho IK; Loh HH; Way EL
    J Pharmacol Exp Ther; 1973 May; 185(2):347-57. PubMed ID: 4350038
    [No Abstract]   [Full Text] [Related]  

  • 11. Delta9-tetrahydrocannabinol and some CNS depressants: evidence for cross-tolerance in the rat.
    Newman LM; Lutz MP; Domino EF
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):254-9. PubMed ID: 4827412
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between tetrahydrocannabinol (THC) and morphine in rats.
    Tulunay FC; Ayhan IH; Sparber SB
    NIDA Res Monogr; 1982 Apr; 41():141-7. PubMed ID: 6289113
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of physical dependence on morphine, codeine and meperidine in the rat by continuous infusion.
    Teiger DG
    J Pharmacol Exp Ther; 1974 Sep; 190(3):408-15. PubMed ID: 4472146
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of chronic and acute 1 -tetrahydrocannabinol pretreatment with zoxazolamine and barbiturates.
    Sofia RD
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):91-8. PubMed ID: 4686112
    [No Abstract]   [Full Text] [Related]  

  • 16. An experimental analysis of behavioral factors in drug dependence.
    Thompson T; Pickens R
    Fed Proc; 1975 Aug; 34(9):1759-70. PubMed ID: 1097265
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats.
    Gellert VF; Sparber SB
    J Pharmacol Exp Ther; 1977 Apr; 201(1):44-54. PubMed ID: 557543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to active constituents of marihuana.
    McMillan DE; Ford RD; Frankenheim JM; Harris RA; Harris LS
    Arch Int Pharmacodyn Ther; 1972; 198(1):132-44. PubMed ID: 5053235
    [No Abstract]   [Full Text] [Related]  

  • 20. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
    Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
    Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.